The device, called the LINX Reflux Management System, is being studied at UC San Diego Medical Center as part of a US and European multicenter clinical trial. Today Europe has announced their approval for the device. The link below gives some additional details from my post last year.
In many areas devices are competing with drugs and with this 20-30 minute procedure and successes it is having, we may have another winner in the device versus drug competition. BD
The company’s Linx device is intended for patients with gastro-esophageal reflux disease, which occurs when stomach juices flowing upward into the esophagus. The disease is caused by defects in the esophageal sphincter muscle, which typically prevents acid and bile from entering the esophagus.